Drug recall
Platelets. Leukocytes Reduced
FDA recall event 27216 · Class III · American National Red Cross Southeastern Michigan Region
Key facts
| Event ID | 27216 |
|---|---|
| Recall numbers | B-0029-4, B-0030-4 |
| Recalling firm | American National Red Cross Southeastern Michigan Region |
| Product type | Biologics |
| Products | Platelets. Leukocytes Reduced, Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, collected an ineligible donor due to use of the medication Megace, were distributed., Blood products, collected from an ineligible donor due to the use of the medication Megace, were distributed. |
| Initiation date | Mar 19, 2003 |
| Termination date | Nov 12, 2003 |
| City | Detroit |
| Country | United States |
| FEI number | 1873044 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports